Description of Study

The purpose of this study is to examine how treatment with different types of external pneumatic compression devices affects recovery following a strenuous lower leg exercise bout.

Location
Exercise and Performance Nutrition Laboratory (Fieldhouse 126) and Fieldhouse 110
209 S Kingshighway St
Saint Charles, MO 63301

Number of Visits
6

Time Commitment
Visit 1: 20 minutes;
Visit 2: 1 hour (Can be combined with Visit 1 - Dependent on Oura ring size);
Visit 3: 2 hours;
Visits 4-6: 4.5 hours each

Compensation
$300 (Direct Deposit)

Point of Contact
Connor Gaige
epnl@lindenwood.edu

Research Sample Needed

• 60 healthy, males and females.

Inclusion Criteria

• In good health absent of being overweight or mildly obese with no other signs or symptoms of cardiovascular, respiratory, metabolic, immune, psychiatric, or musculoskeletal disease or disorders.
• Between the ages of 21 - 45 (no more than 30% of the participants will be under the age of 25).
• Participating in a structured exercise program ≥ 3 days/week.
• BMI is ≤ 30 kg/m^2 and body fat ≤30%.
• Not taking any vasoactive, glycemic-control, pain management related medications or supplements.
• Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, and carry out all study-related procedures.
• Has a smart phone to sync data via Bluetooth to Oura ring app.
• Has a ring size that fits the Oura ring sizes we have ordered.

Exclusion Criteria

• Positive medical history and/or is currently being treated for some form of heart disease, cardiovascular disease.
• Currently being treated for kidney disease, renal failure, or has dialysis performed on regular intervals.
• Has liver disease or some form of clinically diagnosed hepatic impairment.
• Diagnosed with having Type I or Type II diabetes.
• Diagnosed with major affective disorder or other psychiatric disorder that required hospitalization in the prior year.
• Diagnosed with some form of immune disorder (i.e., HIV/AIDS).
• History of cancer (except localized skin cancer without metastases or in situ cervical cancer within 5 years prior to screening visit).
• Positive medical history for any neurological condition or neurological disease.
• Currently prescribed a statin drugs (i.e., Lipitor, Livalo, Crestor, Zocor, etc.) or any hypertension medications (i.e., Beta-blockers, ACE Inhibitors, Alpha blockers, Vasodilators, etc.).
• Current smoker (average of > 1 pack per day within the past 3 months) or has quit within the past six months. This includes all forms of nicotine.
• Intake of any drugs (prescribed or over the counter) or dietary supplements that are vasoactive, glycemic-controlling, or pain management.
• Participants who are lactating, pregnant or planning to become pregnant.
• Outside of the age range.
• Not participating in a structured exercise program ≥ 3 days/week.
• BMI is not ≤ 30 kg/m^2 and body fat is > 30%.
• Is taking medication or supplements that would interfere with study outcomes.
• Does not have a smart phone to sync data via Bluetooth to Oura ring app.
• Ring size is too small or big for an Oura ring, or they have a ring size that does not fit the rings we have ordered.

Are You Eligible?

• Complete initial screening form for this study.

Information provided here reflects current IRB approval for this research. However, this information may be subject to change and updated accordingly.